Adjuvant and neo‐adjuvant immunotherapy in resectable non‐small cell lung cancer (NSCLC): Current status and perspectives
Abstract Surgery followed by adjuvant chemotherapy is the standard of care for selected patients with early‐stage or locally advanced non‐small cell lung cancer (NSCLC). However, many of these patients still experience postoperative recurrence at 5 years. At present, peri‐operative treatment methods...
| Main Authors: | , , , , |
|---|---|
| פורמט: | Article |
| שפה: | English |
| יצא לאור: |
Wiley
2023-02-01
|
| סדרה: | Cancer Innovation |
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1002/cai2.49 |